Article
Feasibility of an Evolutionary Tumor Board for Generating Novel Personalized Therapeutic Strategies
2023-01-19
Abstract excerpt
<h4>ABSTRACT</h4> The current paradigm of clinical trials treating patients until disease progression using maximum tolerated dose does not account for the dynamic tumor-host-drug interactions that result in acquired resistance. Here, we present the concept of an Evolutionary Tumor Board (ETB) and report interim results from a prospective, non-interventional pilot study in which novel therapeutic strategies based...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 099617bc-ac8b-557a-9f8b-d5205ca2a4fd
- DOI
- 10.1101/2023.01.18.23284628
